These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31636386)

  • 1. TFAP2C regulates carbonic anhydrase XII in human breast cancer.
    Franke CM; Gu VW; Grimm BG; Cassady VC; White JR; Weigel RJ; Kulak MV
    Oncogene; 2020 Feb; 39(6):1290-1301. PubMed ID: 31636386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure.
    Woodfield GW; Hitchler MJ; Chen Y; Domann FE; Weigel RJ
    Clin Cancer Res; 2009 Jun; 15(11):3672-9. PubMed ID: 19458056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer.
    Kulak MV; Cyr AR; Woodfield GW; Bogachek M; Spanheimer PM; Li T; Price DH; Domann FE; Weigel RJ
    Oncogene; 2013 Aug; 32(34):4043-51. PubMed ID: 22964634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A
    Wu VT; Kiriazov B; Koch KE; Gu VW; Beck AC; Borcherding N; Li T; Addo P; Wehrspan ZJ; Zhang W; Braun TA; Brown BJ; Band V; Band H; Kulak MV; Weigel RJ
    Mol Cancer Res; 2020 Jan; 18(1):46-56. PubMed ID: 31619506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells.
    Woodfield GW; Chen Y; Bair TB; Domann FE; Weigel RJ
    Genes Chromosomes Cancer; 2010 Oct; 49(10):948-62. PubMed ID: 20629094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib.
    De Andrade JP; Park JM; Gu VW; Woodfield GW; Kulak MV; Lorenzen AW; Wu VT; Van Dorin SE; Spanheimer PM; Weigel RJ
    Mol Cancer Ther; 2016 Mar; 15(3):503-11. PubMed ID: 26832794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.
    Woodfield GW; Horan AD; Chen Y; Weigel RJ
    Cancer Res; 2007 Sep; 67(18):8439-43. PubMed ID: 17875680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of estrogen receptor α expression in breast cancer cells by metastasis-associated protein 1.
    Kang HJ; Lee MH; Kang HL; Kim SH; Ahn JR; Na H; Na TY; Kim YN; Seong JK; Lee MO
    Cancer Res; 2014 Mar; 74(5):1484-94. PubMed ID: 24413532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AP-2γ regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription.
    Tan SK; Lin ZH; Chang CW; Varang V; Chng KR; Pan YF; Yong EL; Sung WK; Cheung E
    EMBO J; 2011 May; 30(13):2569-81. PubMed ID: 21572391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region.
    Orso F; Cottone E; Hasleton MD; Ibbitt JC; Sismondi P; Hurst HC; De Bortoli M
    Biochem J; 2004 Jan; 377(Pt 2):429-38. PubMed ID: 14565844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer.
    Irish JC; Mills JN; Turner-Ivey B; Wilson RC; Guest ST; Rutkovsky A; Dombkowski A; Kappler CS; Hardiman G; Ethier SP
    Mol Oncol; 2016 Jun; 10(6):850-65. PubMed ID: 27005559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TFAP2C expression in breast cancer: correlation with overall survival beyond 10 years of initial diagnosis.
    Perkins SM; Bales C; Vladislav T; Althouse S; Miller KD; Sandusky G; Badve S; Nakshatri H
    Breast Cancer Res Treat; 2015 Aug; 152(3):519-31. PubMed ID: 26160249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy.
    Spanheimer PM; Cyr AR; Gillum MP; Woodfield GW; Askeland RW; Weigel RJ
    Ann Surg; 2014 Apr; 259(4):793-9. PubMed ID: 24045439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERα-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer.
    Lin CL; Tan X; Chen M; Kusi M; Hung CN; Chou CW; Hsu YT; Wang CM; Kirma N; Chen CL; Lin CH; Lathrop KI; Elledge R; Kaklamani VG; Mitsuya K; Huang TH
    BMC Med Genomics; 2020 May; 13(1):69. PubMed ID: 32408897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis.
    Cyr AR; Kulak MV; Park JM; Bogachek MV; Spanheimer PM; Woodfield GW; White-Baer LS; O'Malley YQ; Sugg SL; Olivier AK; Zhang W; Domann FE; Weigel RJ
    Oncogene; 2015 Jan; 34(4):436-44. PubMed ID: 24469049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines.
    Nolens G; Pignon JC; Koopmansch B; Elmoualij B; Zorzi W; De Pauw E; Winkler R
    Breast Cancer Res; 2009; 11(6):R83. PubMed ID: 19906305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of target genes of transcription factor activator protein 2 gamma in breast cancer cells.
    Ailan H; Xiangwen X; Daolong R; Lu G; Xiaofeng D; Xi Q; Xingwang H; Rushi L; Jian Z; Shuanglin X
    BMC Cancer; 2009 Aug; 9():279. PubMed ID: 19671168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients.
    Martínez-Galán J; Torres-Torres B; Núñez MI; López-Peñalver J; Del Moral R; Ruiz De Almodóvar JM; Menjón S; Concha A; Chamorro C; Ríos S; Delgado JR
    BMC Cancer; 2014 Feb; 14():59. PubMed ID: 24495356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival.
    Gee JM; Eloranta JJ; Ibbitt JC; Robertson JF; Ellis IO; Williams T; Nicholson RI; Hurst HC
    J Pathol; 2009 Jan; 217(1):32-41. PubMed ID: 18825690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
    Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
    Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.